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Abstract 
We describe the characteristics of individuals being screened in community settings including factors 
influencing screening decisions and the level of information sought prior to screening. Individuals from 
two community-based radiology clinics (N = 27) were surveyed after screening. Screening efficacy and 
salience were the most important factors in screening decisions, whereas healthcare provider 
recommendations were rated not important. Half of participants reported no or little conversation about 
screening with their primary care provider, and 61.5 percent had not sought any information on screening. 
Individuals being screened in a community setting are unlikely to have sufficient information for an 
informed decision about screening. 
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Introduction
Lung cancer has long been the leading cause of cancer deaths 
among adults in the United States, with 234,030 new cases 
and 154,050 estimated for 2018 (American Cancer Society 
(ACS), 2018). After the National Lung Screening Trial 
(NLST) findings in 2011 showed a substantial relative reduc-
tion in lung cancer mortality with low-dose computed 
tomography (LDCT) screening (Aberle et al. 2011), the US 
Preventive Services Task Force (USPSTF) recommended 
lung cancer screening for specific high-risk populations 
(Moyer and USPSTF, 2014), and in 2015, Medicare and pri-
vate insurance began to provide coverage of LDCT screen-
ing for lung cancer. Following these policy changes, 
advocates, researchers, and health care providers anticipated 
a strong upsurge in screening rates and hoped that lung can-
cer screening might provide a teachable moment regarding 
smoking cessation (Lennes et al., 2018). However, anecdotal 
evidence and two recent studies (Huo et al., 2017; Jemal and 
Fedewa, 2017) have shown lower than expected rates of 
screening among individuals for whom screening is recom-
mended based on their smoking history.
It is important to recognize that recommendations for 
lung cancer screening are more targeted to specific 
populations than other cancer screening recommendations, 
as screening has only been shown to be efficacious in 
reducing mortality in a specific set of individuals. Therefore, 
a general or population-wide increase in screening rates, 
such as has been seen with breast cancer screening inter-
ventions (Anastasi and Lusher, 2017), is not necessarily 
desirable. Rather, lung cancer screening programs should 
aim to raise awareness, provide education, and promote 
engagement in shared decision-making, so that individuals 
have the knowledge and support to determine whether 
screening is right for them. Therefore, provision of infor-
mation and guidelines for shared decision-making regard-
ing lung cancer screening must be cognizant of the attitudes, 
motivations, and information needs of individuals who are 
making decisions about lung cancer screening.
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Along these lines, a number of recent studies have 
explored individuals’ attitudes toward and interest in lung 
cancer screening. For example, Lillie et al. (2018) found 
that need for cognitive closure was not associated with lung 
cancer screening uptake in veterans. However, for the most 
part, these studies have focused on individuals participating 
in a lung cancer screening trial (e.g. Patel et al., 2012; Van 
den Bergh et al., 2009) or are survey studies of individuals 
who are not and/or have not been screened for lung cancer, 
but rather have been recruited from the general public or 
through a primary care setting (e.g. Delmerico et al., 2014; 
Jonnalagadda et al., 2012; Pallin et al., 2012; Silvestri et al., 
2007; Tanner et al., 2013). Therefore, there is a lack of 
information in the literature about factors affecting screen-
ing decisions, attitudes toward screening, and information 
sought about screening in individuals who are actually 
undergoing screening lung cancer screening outside of a 
research setting. Although these data were collected before 
the NLST results, we nevertheless believe that the choice 
setting represented in our study is more relevant and com-
parable to current community-based settings for decision-
making about lung cancer screening than other studies 
undertaken in the context of a trial or hypothetical (survey) 
choice situation.
The study reported here addresses this gap in knowledge 
by presenting information collected from individuals 
receiving lung cancer screening in a community setting. 
Although these data pre-date the NLST trial results and 
subsequent policy changes, the decisions made regarding 
screening reported here closely mirror actual community-
based decisions about screening than the more frequently 
studied situations of screening in a screening trial setting or 
hypothetical screening questions.
Materials and methods
Participants and procedures
Eligible participants for this study were adults who had pre-
viously received at least one LDCT between February 2008 
and June 2009 at one of two community-based direct out-
patient radiology clinics in Florida and Kentucky. The 
study sample was recruited through two means: (1) the 
clinics distributed study flyers as potentially eligible 
patients arrived for their LDCT and (2) the clinics mailed 
an invitation letter to the 92 patients who had received an 
LDCT any time within the past year (Florida study site: 50 
patients; Kentucky study site: 42 patients). Interested par-
ticipants self-referred into the study. Participation was open 
regardless of gender, age, and race/ethnicity; however, indi-
viduals were excluded if they were incapable of completing 
a survey in English. Eligibility was confirmed and informed 
consent subsequently obtained either at the study site 
(Kentucky study site) or via telephone or mail (Florida 
study site). The survey was completed either during a 
scheduled study visit (Kentucky study site) or via mail 
(Florida study site). Participants received a US$60 gift card 
after completing the survey. The protocol was approved by 
the Institutional Review Boards of the University of Miami 
and the University of Kentucky.
Measures
Sample characteristics. Participants reported basic demo-
graphics (e.g. age, gender, race/ethnicity, highest educa-
tional attainment, marital status, employment status, annual 
household income), as well as general health, type of insur-
ance, smoking history, and number of previous LDCT 
scans (including results) on the survey. In addition, indi-
viduals were asked whether they believed that they were at 
risk for developing lung cancer (yes/no).
Factors important in the decision to be screened for lung can-
cer. To identify possible influences on the decision to be 
screened in the community setting, participants rated 22 
decision-making factors which potentially affected their 
past decision to be screened for lung cancer and 8 decision-
making factors which might affect future LDCT decision-
making. The factors were rated on a 10-point Likert-type 
scale (1 = not at all important to 10 = very important) and 
addressed barriers to screening, screening clinic and physi-
cian characteristics, screening efficacy, fear, social influ-
ence, lung cancer screening attributes, and salience (see 
Table 2 for the complete list of factors and results). The 
specific factors were selected as likely relevant to lung can-
cer screening decision-making from a systematic literature 
review as well as health behavior theory (Ajzen, 1991; 
Becker, 1974; Carter-Harris et al., 2016). For analyses, fac-
tors were categorized into three groups based on the overall 
mean scores: not important = 1–4.9, somewhat impor-
tant = 5–7.9, and very important = 8–10. A mean summary 
importance score was also calculated.
Sources of lung cancer screening information. Main sources of 
lung cancer screening information were assessed in two 
ways. First, participants were asked to what degree they 
had discussed lung cancer screening with any of the follow-
ing people: family, friends, primary care physician, other 
physicians, nurses, others (response options: never, a little 
bit, some, a fair bit, extensively). Second, respondents indi-
cated whether they had sought information on lung cancer 
screening from any of the following sources: screening 
center website, other Internet sites, a cancer hotline such as 
the Cancer Information Service operated by the National 
Cancer Institute, a community health center, or another 
source (write-in answer).
Evaluation of lung cancer screening decision. Participants 
assessed their overall lung cancer screening experience 
using a 5-point Likert-type scale (1 = very negative to 
Byrne et al. 3
5 = very positive) and asked whether they would be inter-
ested in future lung cancer screening using a 5-point Likert-
type scale (1 = definitely no to 5 = definitely yes). 
Participants also completed three validated scales to evalu-
ate their screening decision: (1) the 5-item Decision Regret 
Scale (Brehaut et al., 2003), which measures distress or 
remorse after a healthcare decision (1 = strongly agree to 
5 = strongly disagree; higher mean scores indicate lower 
decision regret), with a sixth lung cancer–specific item (“I 
am aware of the choices I have to participate in lung cancer 
screening”); (2) the 6-item Satisfaction with Decision Scale 
(Holmes-Rovner et al., 1996), which measures participants’ 
satisfaction with a health care decision (1 = lowest satisfac-
tion to 5 = highest satisfaction; higher mean scores indicate 
higher decision satisfaction); and (3) the 16-item Deci-
sional Conflict Scale (O’Connor, 1995), which measures 
personal perceptions of decision uncertainty (0 = strongly 
agree to 4 = strongly disagree; higher mean scores indicate 
greater decisional conflict) using five sub-scales that focus 
on uncertainty, informed, values clarity, support, and effec-
tive decisions.
Statistical analyses
We report means and standard deviations for continuous 
variables and frequencies and percentages for all other data. 
Group differences in factors important to screening deci-
sions were compared by smoking status, gender, and age. 
Comparisons of mean differences in decision regret, deci-
sion satisfaction, and decisional conflict by smoking status, 
gender, and age were performed using t tests. Because a 
significant difference in age was found between the 
Kentucky and Florida subsets of the sample, we explored 
conducting analyses stratified by location. However, 
because of concerns of small sample size and multiple 
comparisons leading to potentially spurious significant 
results, we do not include those analyses here. All analyses 
were performed using STATA v. 13 (StataCorp LP, College 
Station, TX, USA).
Results
Sample characteristics
There were 27 individuals undergoing LDCT-based lung 
cancer screening in our two community clinics who partici-
pated in our survey. The Florida study site recruited 13 par-
ticipants through the study invitation letter (26% response 
rate), and the Kentucky study site recruited 14 participants 
through the study invitation letter (n = 13; 31% response 
rate) and the clinic-distributed flyers (n = 1). Participants 
had an average age of 59.5 years (standard deviation (SD) 
9.1). They were primarily female (61.5%), White (92.3%), 
and living with a spouse (80.8%). Reflecting the lack of 
insurance or Medicare coverage of screening at the time, 
our study population was financially stable: 48.2 percent 
were in the highest income bracket (over US$75,000/year), 
63.0 percent had private insurance, and 57.7 percent had at 
least a college degree. The majority of respondents reported 
themselves as healthy (92.6%) and 63.0 percent were not 
current smokers. Just over half (n = 15; 55.6%) of partici-
pants had received only one previous LDCT scan, and 
74.1 percent believed that they were at risk of developing 
lung cancer. There were no statistically significant differ-
ences between participants drawn from the Kentucky and 
Miami study sites on gender, race/ethnicity, highest educa-
tional attainment, annual household income, general health 
status, or smoking status (current vs former smoker). 
However, participants from the Kentucky study site were 
younger than those from the Florida study site (mean age 
56.0 vs 63.7, p = 0.03). Full participant characteristics are 
presented in Table 1.
We compared the demographic characteristics of our 
study sample to that of the communities from which they 
originate (from US Census Bureau 2016 American 
Community Survey 5-year estimates, Boca Raton, FL (FL) 
and Lexington, KY (KY), respectively). The study sample 
is somewhat older (median age 46.3 FL and 34.1 KY), had 
a higher percentage of women (51.5% FL and 50.9% KY, in 
Lexington), but had similar racial demographics (88.6% 
White in FL and 75.8% White in KY).
Factors important in the decision to be screened 
for lung cancer
Participants’ ratings of the importance of factors affecting 
past and future lung cancer screening decisions are shown 
in Table 2. Overall, the most important factor in the deci-
sion to be screened was the ability to detect lung cancer 
early (mean: 9.93, SD 0.38). The majority of factors desig-
nated as very important related to lung cancer screening 
attributes and efficacy: being forewarned of any potential 
future health problems (mean: 9.37, SD 1.57), reassurance 
that one’s lungs were healthy (mean: 9.31, SD 2.02), reduc-
ing the risk of dying from lung cancer (mean: 9.22, SD 
2.15), and screening having no major side effects (mean: 
8.30, SD 2.84). Other factors rated very important were 
considering health to be very important (mean: 9.58, SD 
1.03) and the fear of being diagnosed with lung cancer 
(mean: 8.16, SD 3.12).
The majority of factors relating to social influence were 
identified as not important in the lung cancer screening 
decision, including a doctor’s recommendation (mean: 
4.42, SD 4.27). Although the participants identified the cost 
of lung cancer screening as a somewhat important factor 
(mean: 6.48, SD 3.30), they identified the two factors 
related to cost-cutting as not important: having a coupon to 
reduce the cost of screening (mean: 4.25, SD 3.97) and 
receiving a discount on screening (mean: 4.71, SD 3.84).
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With regard to factors potentially affecting future screen-
ing, participants identified most barriers or clinic attributes 
as very important (not waiting long to get an appointment, 
ease of scheduling, and being seen on time) or somewhat 
important (that the results were explained by a physician at 
the center, the pleasantness of the staff at the center, how 
inviting the clinic was, and how close the clinic was to 
home). Only one factor, how close the clinic was to work, 
was identified as not important in future lung cancer screen-
ing decision-making (mean: 3.88, SD 3.26).
Variations in factors important to lung cancer 
screening uptake
As shown in Table 2, there were statistically significant 
variations in importance ratings by smoking status, gender, 
and age. In some of these instances, the differences are sub-
stantial enough so that stratifying the population responses 
leads to a different categorization of importance of a factor 
for the different population strata. These instances are high-
lighted below in labeling each factor as NI = not important, 
SI = somewhat important, and VI = very important for those 
cases where the stratified analyses result in different cate-
gorizations for different subpopulations.
Not surprisingly, smokers reported smoking history (SI 
overall) being of more importance to lung cancer screening 
decision-making than did non-smokers (9.40 (VI) vs 6.50 
(SI)). Using a summary measure, women globally rated all 
decision-making factors more importantly than did men: 
7.10 vs 5.58. Specifically, attributes of the lung cancer 
screening test and results seemed to be more important to 
women than to men (i.e. low false-positive rate (SI overall): 
6.87 (SI) vs 4.33 (NI); painless screening exam (SI over-
all): 8.63 (VI) vs 6.30 (SI); ability of screening to reduce 
the risk of dying from lung cancer: 9.75 vs 8.30), as were 
clinic/physician attribute associations with future screening 
decisions (how inviting the clinic was: 7.31 vs 5.10; pleas-
antness of the staff at the center (SI overall): 8.25 (VI) vs 
5.20 (SI); being seen on time for the appointment (VI 
Table 1. Sample characteristics (n = 27).
Variable n (%)a
Age, mean (SD) (years) 59.5 (9.06)
Gender
 Male 10 (38.5)
 Female 16 (61.5)
Race/ethnicity
 White, non-Hispanic 24 (92.3)
 Black 2 (7.7)
 Other 0 (0)
Highest level of education
 High school graduate or less 3 (11.5)
 Some technical or college training 8 (30.7)
 College graduate 6 (23.1)
 Postgraduate work 9 (34.6)
Marital statusb
 Live with spouse 21 (80.8)
 Live with children 2 (7.7)
 Live alone 4 (15.4)
 Other 3 (11.5)
Work outside of the home
 Yes, full-time 13 (48.2)
 Yes, part-time 4 (14.8)
 No 10 (37.0)
Household income
 Less than US$20,000 2 (7.4)
 US$20,000–35,000 2 (11.1)
 US$35,000–50,000 4 (14.8)
 US$50,000–75,000 2 (7.4)
 Over US$75,000 13 (48.2)
 Refused 3 (11.1)
General health
 Excellent 6 (22.2)
 Very good 8 (29.6)
 Good 11 (40.7)
 Fair 2 (7.4)
 Poor 0 (0)
Insuranceb
 Private 17 (63.0)
 Medicare 7 (25.9)
 Medicaid 1 (3.7)
 VA 3 (11.1)
 No insurance 5 (18.5)
Smoking history
 Never smoker 5 (18.5)
 Former smoker 12 (44.4)
 Current smoker 10 (37.1)
 Pack year exposure, mean (SD) 22.3 (16.6)
Previous LDCT
 1 15 (57.7)
 2 or more 10 (38.5)
Do you believe that you are at risk for lung cancer?
 Yes 20 (74.1%)
 No 7 (25.9%)
Variable n (%)a
Compared to others your same age, how would you describe 
your risk for lung cancer?
 A lot lower than average 2 (7.4)
 Lower than average 3 (11.1)
 About average 6 (22.2)
 Higher than average 9 (33.3)
 A lot higher than average 7 (25.9)
SD: standard deviation; LDCT: low-dose computed tomography.
aPercentages may not sum to 100 percent due to non-response.
bRespondents checked all that applied.
Table 1. (Continued)
Byrne et al. 5
Table 2. Factors important to lung cancer screening decisions (n = 27).
Mean (SD)a Significant associations
 Smoking status
Current vs former/
never
Gender
Female vs male
Age
⩽60 vs >60
Previous lung cancer screening decision  
Factors rated not important  
A friend thought they should be screened (I) 2.40 (2.90) NS 2.73 vs 1.00* NS
A friend recommended the screening (I) 2.46 (2.96) NS 3.00 vs 1.00* NS
A friend had the same type of screening before (I) 3.12 (3.54) NS 4.07 vs 1.00** NS
A family member had the same type of screening (I) 3.88 (3.75) NS NS NS
A family member recommended the screening (I) 4.08 (3.98) NS NS NS
A family member thought they should be screened (I) 4.13 (3.87) NS NS NS
They had a coupon to reduce the cost of screening (B) 4.25 (3.97) NS 5.21 vs 2.11* NS
A doctor recommended the screening (I) 4.42 (4.27) NS NS NS
They received a discount on the screening (B) 4.71 (3.84) NS 5.93 vs 2.22** NS
Factors rated somewhat important  
They saw or heard an advertisement for the screening on the 
TV, newspaper, or radio (I)
6.04 (3.85) NS NS NS
The low false-positive rate (L) 6.08 (3.58) NS 6.87 vs 4.33* NS
The cost of the screening exam (B) 6.48 (3.30) NS NS NS
Their smoking history (S) 7.62 (3.81) 9.40 vs 6.50* NS NS
Whether the lung screening physician is board certified (C) 7.78 (3.32) NS NS NS
That the screening exam was painless (L) 7.81 (3.06) NS 8.63 vs 6.30* NS
Factors rated very important  
Fear of being diagnosed with lung cancer (F) 8.16 (3.12) NS NS NS
That screening had no major side effects (L) 8.30 (2.84) NS NS NS
The ability of screening to reduce the risk of dying from lung 
cancer (E)
9.22 (2.15) NS 9.75 vs 8.30* NS
They wanted to be reassured that their lungs were healthy (L) 9.31 (2.02) NS NS NS
Being forewarned of any potential future health problems (L) 9.37 (1.57) NS NS NS
Because their health is very important to them (S) 9.58 (1.03) NS NS 9.08 vs 10**
The ability of screening to detect lung cancer early (E) 9.93 (0.38) NS NS NS
Future lung cancer screening decision  
Factors rated not important  
How close the clinic was to work (B) 3.88 (3.26) NS NS NS
Factors rated somewhat important  
How close the clinic was to home (B) 6.04 (3.07) NS NS NS
How inviting the clinic was (C) 6.59 (3.07) NS 7.31 vs 5.10* NS
The pleasantness of the staff at the center (C) 7.19 (2.77) NS 8.25 vs 5.20** NS
The results were explained by a physician at the center (C) 7.23 (3.65) NS NS 5.75 vs 8.50*
Factors rated very important  
That they would be seen on time for appointment (C) 8.22 (2.45) NS 9.06 vs 6.70** NS
That it was easy to schedule the appointment (B) 8.33 (2.35) NS NS NS
That they did not have to wait very long to get an 
appointment (C)
8.48 (2.34) NS NS NS
B: barriers; C: clinic/physician attributes; E: efficacy of screening; F: fear; I: social influence; L: lung cancer screening attributes; S: salience; NS: not 
significant.
aScale of 1–10 with 1 being “not at all important” and 10 being “very important.”
*p < 0.05; **p < 0.01.
overall): 9.06 (VI) vs 6.70 (SI)). In addition, women rated 
the social influence of friends and some financial factors, 
indicating cost-related barriers, as more important than 
men. However, despite between-group differences, both 
men and women identified these factors as generally unim-
portant. Finally, older adults rated a screening center 
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physician explaining the LDCT results (SI overall) (8.50 
(VI) vs 5.75 (SI)) and the importance of their own health 
(10.00 vs 9.08) as more important than younger adults.
Sources of lung cancer screening information
Figure 1 shows the extent of screening discussions that par-
ticipants engaged in with specific types of people. Overall, 
most participants did not extensively discuss lung cancer 
screening with any category of potential discussants before 
being screened. In describing the extent of discussions 
about lung cancer screening, 37.5 percent of participants 
revealed that they had never spoken with a primary care 
physician before being screened. Similarly, 36.0 percent 
had never spoken with family members and 52.2 percent 
never with friends about lung cancer screening before 
screening. Overall, 18.5 percent of participants selected 
“never” for all categories in Figure 1, indicating that they 
had not spoken with anyone before being screened.
In addition, participants were asked whether they had 
sought information from a variety of sources such as the 
Internet, a telephone call in line such as the Cancer 
Information Service, or other. The majority (61.5%) indi-
cated that they had not sought information from any sources. 
Of the 11 individuals, 10 who reported seeking information 
used Internet-based resources, predominantly the webpage 
of the specific radiology clinic where they were screened.
Evaluation of lung cancer screening decision
The majority of participants indicated that they had a posi-
tive or very positive lung cancer screening experience 
(85.2%) and would “probably” or “definitely” be screened 
again (88.9%). No participant reported having a very nega-
tive screening experience.
Figure 2 shows how participants evaluated their lung can-
cer screening decision as measured by several validated sur-
vey instruments related to decision-making. Results are 
given for the overall population and for the population strati-
fied by smoking status, gender, and age category. Participants 
indicated low decisional regret (mean: 26.58, SD 4.62) and 
high satisfaction with the decision (mean: 26.04, SD 6.46). 
For decisional regret, where higher scores indicate less 
regret, women had significantly lower decisional regret than 
did men (mean: 28.2 vs 25.6). Younger individuals had 
higher decision satisfaction than did older individuals (mean: 
28.1 vs 23.6). Participants reported low conflict levels based 
on the Decisional Conflict Scale (mean score: 21.2, SD 
18.6), with women and current smokers having lower deci-
sional conflict than men and former smokers (mean: 25.20 vs 
32.3, 26.1 vs 31.8, respectively).
Discussion
In an effort to understand the factors that were important to 
individuals who were early adopters of lung cancer screen-
ing, we collected novel information from an important and 
unique sample of individuals who had been screened for 
lung cancer with LDCT in community settings. Although 
these individuals were screened prior to the NLST results 
and coverage of screening, their responses are more rele-
vant than most previous studies reporting this information, 
as these people had made real—as opposed to hypotheti-
cal—decisions about screening and were screened in the 
Figure 1. Lung cancer screening discussions (n = 27).
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Figure 2. Evaluation of lung cancer screening decision (n = 27).
community as opposed to being screened within an ongo-
ing screening trial. Overall, these results suggest that par-
ticipants positively appraised their lung cancer screening, 
and they elected to pursue screening with an expectation 
that it would effectively detect lung cancer early, implicitly 
reduce the risk of lung cancer death, and/or definitively 
ascertain lung health.
Several findings from this study are especially notewor-
thy and warrant consideration alongside efforts to implement 
high-quality lung cancer screening among individuals at 
high risk of lung cancer across the nation and globally. First, 
our results identify a largely homogeneous population who 
received LDCT-based lung cancer screening. Despite being 
from different locations, the demographics of our sample 
indicate a White, female, and financially stable group of 
screeners who, despite their high level of education, did not 
seek much information prior to screening. In addition, 
despite their elevated perceived lung cancer risk, these indi-
viduals were not uniformly at high risk for lung cancer. In 
fact, the majority (70%) of our participants would not meet 
the USPSTF recommended criteria for screening.
Second, we found that there were interesting variations 
by participant characteristics in both the identification of 
important lung cancer screening decision-making factors 
and the evaluation of lung cancer screening. In some 
cases, stratified analyses resulted in disparate classifica-
tions of the importance of a factor for different subpopula-
tions. (Note, however, that the classification definitions 
were subjective and not statistically determined.) Female 
participants globally rated decision-making factors more 
important than their counterparts and specifically rated 
screening efficacy factors, clinic attribute factors, and 
cost-related barrier factors more important than did men. 
Although social influence factors were rated as relatively 
unimportant to decision-making overall, women valued 
these factors significantly more than men. In contrast to 
finding that social influence was not important in lung 
cancer screening decisions in this population, Braybrook 
et al. (2011) reported that family members improved 
men’s awareness of lung cancer screening, especially if a 
family member already had cancer. Therefore, it is unclear 
what role family members may play in uptake of lung can-
cer screening in response to newly crafted screening 
guidelines. In families with a family history of lung can-
cer, this might engender support for screening; however, 
family communication patterns regarding smoking and 
tobacco cessation efforts might actually complicate efforts 
to raise awareness or encourage consideration of lung 
cancer screening.
Women also experienced lower decision regret and 
lower decisional conflict regarding lung cancer screening 
participation decisions. Older individuals placed more 
importance on screening center physicians explaining the 
lung cancer screening results and the importance of their 
own health and experienced lower decision satisfaction 
than younger participants. Not surprisingly, current smok-
ers placed more importance on their smoking history; for-
mer and never smokers placed importance on their health in 
general and experienced higher decisional conflict in the 
informed and values clarity domains, indicating that non-
smokers receiving lung cancer screening were least pre-
pared to make informed choices. This follows previous 
research findings that current, former, and never smokers 
have disparate attitudes toward lung cancer screening 
(Jonnalagadda et al., 2012).
Finally, and perhaps most striking, our results suggest 
that informed decision-making for lung cancer screening 
was not occurring among all participants. A healthcare 
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provider recommendation for lung cancer screening was 
not highly valued, nor was healthcare provider consultation 
commonly sought. While physicians currently lack detailed 
knowledge regarding lung cancer screening efficacy, evi-
dence, and guidelines (Klabunde et al., 2012), alternative 
information sources, such as direct to consumer advertis-
ing, commonly focus solely on benefits and do not impart 
adequate knowledge of screening harms (Illes et al., 2004). 
Indeed, early adopters emphasized the benefits of lung can-
cer screening, as they classified these factors as very impor-
tant but did not call attention to potential harms. This 
finding follows a general trend of people overestimating 
benefits of screening and underestimating harms (Schwartz 
et al., 2004) and is of notable concern in the context of 
LDCT-based lung cancer screening; there are a number of 
significant high-probability and low-probability harms 
associated with screening and follow-up procedures, 
including overdiagnosis (Patz et al., 2014), high rates of 
false positives and indeterminate pulmonary nodules, and 
significant incidental findings (Aberle et al., 2011; Petersen, 
2014) that may lead to psychosocial distress (Byrne et al., 
2008; Slatore et al., 2014; Van den Bergh et al., 2010; 
Wiener et al., 2015), increased health care resources (Byrne 
et al., 2010; Weiner et al., 2014), and the provision of 
unnecessary biopsies (Wiener et al., 2011), that warrant 
consideration in the decision-making process and could 
impact follow-up and program adherence if not properly 
addressed prior to screening.
Study strengths and limitations
There are several limitations to this largely descriptive study 
of early lung cancer screening adopters. First, the data are 
from a period prior to release of the NLST findings and 
changes in recommendations for lung cancer screening. 
However, as described in the “Introduction” section, the 
“choice setting” for this study more closely emulates the 
current situation for most individuals making decisions 
about lung cancer screening than more recently collected 
data which use hypothetical survey responses or individuals 
being screened in the context of a clinical trial. Second, we 
report on a small sample size with no ability to comment on 
survey non-respondents. However, these data may be help-
ful in designing subsequent research in this emerging area of 
lung cancer prevention and control. Third, this study 
describes individuals living in two relatively different com-
munities who paid out-of-pocket for LDCT-based lung can-
cer screening prior to the updated USPSTF guideline. 
Results cannot be reliably generalized to other populations 
but may provide guidance for subsequent development of 
interventions seeking to support informed and shared deci-
sion-making about lung cancer screening participation. 
Finally, the data collected in this study were self-reported; 
there may be potential for some degree of responder bias 
and recall bias, given that some participants had participated 
in screening up to 12 months prior to participation. Despite 
these limitations, data collected from lung cancer screening 
early adopters who sought and received lung cancer screen-
ing offer a unique and valuable perspective on lung cancer 
screening decision-making as implementation expands. To 
our knowledge, no other studies have reported data from 
similar populations undergoing lung cancer screening in a 
community setting and outside of a clinical trial.
Conclusion
This study found that individuals who received LDCT-
based lung cancer screening in a community setting gener-
ally viewed screening in a highly positive light. However, 
on the whole, individuals being screened did not seek 
detailed information about screening nor consulted trusted 
health care clinicians about this decision. The paucity of 
discussions between screeners and health care clinicians 
runs counter to current lung cancer screening guidelines, 
which strongly emphasize, and in some contexts mandate, 
integration of patient counseling practices using shared 
decision-making. These guidelines stress the importance of 
informed patients making screening choices in collabora-
tion with healthcare providers who communicate the bal-
ance of benefits, harms, and the uncertainties of screening 
(Weiner and Slatore, 2013). To achieve the shared decision-
making standards set forth by the Centers for Medicare & 
Medicaid Services, efforts are needed to develop, rigor-
ously evaluate, and promote the use of evidence-based lung 
cancer screening decision tools. These tools need to pro-
vide patients with unbiased information about the potential 
sequelae of screening, facilitate informed decision-making, 
and encourage discussions with healthcare clinicians.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with 
respect to the research, authorship, and/or publication of this 
article.
Funding
The author(s) disclosed receipt of the following financial support 
for the research, authorship, and/or publication of this article: 
M.M.B. was funded through NIH NCI K07 CA 101812 
(Pennsylvania), S.E.L. through the VA HSR&D Associated 
Health Postdoctoral Fellowship (Minnesota), and J.L.S. through 
an Investigator-Initiated Grant from the Kentucky Lung Cancer 
Research Program (Kentucky). The funding sources had no 
involvement in the study design; in the collection, analysis, and 
interpretation of the data; in the writing of the report; and in the 
decision to submit the article for publication.
References
Aberle DR, Adams AM, Berg CD, et al. (2011) Reduced lung-
cancer mortality with low-dose computed tomographic 
screening. New England Journal of Medicine 365: 395–409.
Byrne et al. 9
Ajzen I (1991) The theory of planned behavior. Organizational 
Behavior and Human Decision Processes 50: 179–211.
American Cancer Society (ACS) (2018) Cancer Facts & Figures. 
Atlanta, GA: ACS.
Anastasi N and Lusher J (2017) The impact of breast cancer 
awareness interventions on breast screening uptake among 
women in the United Kingdom: A systematic review. 
Journal of Health Psychology. Epub ahead of print 1 March. 
DOI: 10.1177/1359105317697812.
Becker MH (ed.) (1974) The health belief model and personal 
health behavior. Health Education Monographs 2: 324–508.
Braybook DE, Witty KR and Robertson S (2011) Men and lung 
cancer: A review of the barriers and facilitators to male 
engagement in symptom reporting and screening. Journal of 
Men’s Health 8: 93–99.
Brehaut JC, O’Connor AM, Wood TJ, et al. (2003) Validation 
of a Decision Regret Scale. Medical Decision Making 23: 
281–292.
Byrne MM, Koru-Sengul T, Zhao W, et al. (2010) Healthcare use 
after screening for lung cancer. Cancer 116: 4793–4799.
Byrne MM, Weissfeld J and Roberts MS (2008) Anxiety, fear of 
cancer, and perceived risk of cancer following lung cancer 
screening. Medical Decision Making 28: 917–925.
Carter-Harris L, Tan AS, Salloum RG, et al. (2016) Patient-
provider discussions about lung cancer screening pre- and 
post-guidelines: Health Information National Trends Survey 
(HINTS). Patient Education and Counseling 99: 1772–1777.
Delmerico J, Hyland A, Celestino P, et al. (2014) Patient will-
ingness and barriers to receiving a CT scan for lung cancer 
screening. Lung Cancer 84: 307–309.
Holmes-Rovner M, Kroll J, Schmitt N, et al. (1996) Patient satis-
faction with health care decisions: The satisfaction with deci-
sion scale. Medical Decision Making 16: 58–64.
Huo J, Shen C, Volk RJ, et al. (2017) Use of CT and chest radiog-
raphy for lung cancer screening before and after publication 
of screening guidelines: Intended and unintended uptake. 
JAMA Internal Medicine 177: 439–441.
Illes J, Kann D, Karetsky K, et al. (2004) Advertising, patient deci-
sion making, and self-referral for computed tomographic and 
magnetic resonance imaging. Archives of Internal Medicine 
164: 2415–2419.
Jemal A and Fedewa SA (2017) Lung cancer screening with low-
dose computed tomography in the United States—2010 to 
2015. JAMA Oncology 3(9): 1278–1281.
Jonnalagadda S, Bergamo C, Lin JJ, et al. (2012) Beliefs and 
attitudes about lung cancer screening among smokers. Lung 
Cancer 77: 526–531.
Klabunde CN, Marcus PM, Han PK, et al. (2012) Lung can-
cer screening practices of primary care physicians: Results 
from a national survey. Annals of Family Medicine 10: 
102–110.
Lennes IT, Luberto CM, Carr AL, et al. (2018) Project reach: 
Piloting a risk-tailored smoking cessation intervention for 
lung screening. Journal of Health Psychology. Epub ahead 
of print 1 February. DOI: 10.1177/135910538756500.
Lillie SE, Fu SS, Fabbrini AE, et al. (2018) Does need for cognitive 
closure explain individual differences in lung cancer screen-
ing? A brief report. Journal of Health Psychology. Epub 
ahead of print 1 January. DOI: 10.1177/1359105317750253.
Moyer VA and US Preventive Services Task Force (USPSTF) 
(2014) Screening for lung cancer: U.S. Preventive Services 
Task Force recommendation statement. Annals of Internal 
Medicine 160: 330–338.
O’Connor AM (1995) Validation of a decisional conflict scale. 
Medical Decision Making 15: 25–30.
Pallin M, Walsh S, O’Driscoll MF, et al. (2012) Overwhelming 
support among urban Irish COPD patients for lung cancer 
screening by low-dose CT scan. Lung 190: 621–628.
Patel D, Akporobaro A, Chinyanganya N, et al. (2012) Attitudes 
to participation in a lung cancer screening trial: A qualitative 
study. Thorax 67: 418–425.
Patz EF Jr, Pinsky P, Gatsonis C, et al. (2014) Overdiagnosis in 
low-dose computed tomography screening for lung cancer. 
JAMA Internal Medicine 174: 269–274.
Petersen H (2014) Incidentally discovered pulmonary nodules. 
JAAPA 27: 25–32.
Schwartz LM, Woloshin S, Fowler FJ, et al. (2004) Enthusiasm 
for cancer screening in the United States. JAMA 291: 71–78.
Silvestri GA, Nietert PJ, Zoller J, et al. (2007) Attitudes towards 
screening for lung cancer among smokers and their non-
smoking counterparts. Thorax 62: 126–130.
Slatore CG, Sullivan DR, Pappas M, et al. (2014) Patient-centered 
outcomes among lung cancer screening recipients with com-
puted tomography: A systematic review. Journal of Thoracic 
Oncology 9: 927–934.
Tanner NT, Egede LE, Shamblin C, et al. (2013) Attitudes and 
beliefs toward lung cancer screening among US Veterans. 
Chest 144: 1783–1787.
Van den Bergh KA, Essink-Bot ML, Borsboom GJ, et al. (2010) 
Short-term health-related quality of life consequences in a 
lung cancer CT screening trial (NELSON). British Journal 
of Cancer 102: 27–34.
Van den Bergh KA, Essink-Bot ML, van Klaveren RJ, et al. 
(2009) Informed participation in a randomised controlled 
trial of computed tomography screening for lung cancer. 
European Respiratory Journal 34: 711–720.
Weiner RS and Slatore CG (2013) Framing discussions about CT 
scan screening for lung cancer so that patients see the whole 
picture. Chest 144: 1749–1750.
Weiner RS, Gould MK, Slatore CG, et al. (2014) Resource use 
and guideline concordance in evaluation of pulmonary nod-
ules for cancer: Too much and too little care. JAMA Internal 
Medicine 174: 871–880.
Wiener RS, Gould MK, Woloshin S, et al. (2015) “The thing is not 
knowing”: Patients’ perspectives on surveillance of an inde-
terminate pulmonary nodule. Health Expect 18: 355–365.
Wiener RS, Schwartz LM, Woloshin S, et al. (2011) Population-
based risk for complications after transthoracic needle lung 
biopsy of a pulmonary nodule: An analysis of discharge 
records. Annals of Internal Medicine 155: 137–144.
